Pearl River Capital, LLC Axsome Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$57.42 - $83.61 $237,087 - $345,225	-4,129 Reduced 41.56%	5,806 $462,000
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $446,870 - $530,501	-6,453 Reduced 39.38%	9,935 $694,000
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $395,202 - $611,308	6,766 Added 70.32%	16,388 $1.18 Million
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $114,444 - $147,000	1,960 Added 25.58%	9,622 $593,000
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $306,020 - $610,814	7,662 New	7,662 $590,000
Q2 2020 Aug 10, 2020	SELL	$49.87 - $98.69 $173,198 - $342,750	-3,473 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$41.2 - $101.31 $143,087 - $351,849	3,473 New	3,473 $204,000

288

40.4M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.88B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.